Arm Holdings ARM Stock, September 2026: Record Revenue and an Unexplained 8.7% Drop

Arm Holdings shares fell 8.7% on September 28, 2026 with no reported catalyst, even as FY2026 revenue reached $4.92 billion and capital expenditure surged 148.9% to $545 million.

Arm Holdings shares fell 8.7% on September 28, 2026, closing at $283.33. No published report in Slicast's coverage explains the proximate cause; it stands, at this writing, as an unattributed market event. That absence of a clear catalyst is itself notable for a company whose earnings and filings cycle had, until Monday's session, provided a broadly positive backdrop.

The operating backdrop is one of momentum. Arm delivered a record first quarter for total revenue in the period ended June 30, 2026 — its fiscal first quarter of 2027 — with growth attributed to AI chip design licenses from multiple semiconductor suppliers. That result capped a fiscal year 2026 in which group revenue reached $4.92 billion, according to Slicast's XBRL-sourced compilation. On September 18, 2026, the company filed its full annual report on Form 6-K for the year ended March 31, 2026, a statutory disclosure covering the strategic, governance and remuneration dimensions of the business. The annual general meeting, held on September 9, 2026, voted on resolutions by poll.

What has shifted more sharply than revenue is the pace of capital deployment. Arm's capital expenditure reached $545 million in fiscal 2026, up 148.9% from $219 million the prior year; the single quarter ended June 30, 2026 absorbed $197 million, the largest quarterly figure in Slicast's seventeen-period data series extending back to 2022. At 11% of FY2026 revenue, capex intensity places Arm fifth among fifteen chip-sector peers tracked by Slicast, below category leader Micron Technology but above the group median. The trajectory implies meaningful commitment to physical and computational infrastructure, even though Arm's licensing model means it does not manufacture silicon itself.

The investment posture extends to the venture side. Arm participated in a $312 million funding round for Olix, a startup developing AI inference accelerators for data centers, in a transaction reported in August 2026 — the round was structured in euros at €270.5 million.

The longer arc matters here. Arm survived a proposed acquisition by Nvidia — announced at up to $40 billion in September 2020 and ultimately blocked by regulators — before listing on Nasdaq in 2023. The strategic question that battle foregrounded — whether Arm's architecture-neutral intermediary status in the chip ecosystem could survive concentration in a single customer's hands — has not been resolved, only deferred. Every major AI chip designer, from incumbent chipmakers to a new generation of hyperscaler custom-silicon programs, operates on Arm. That breadth is the commercial model's core strength, and it is what the rising capex and the Olix bet are both designed to defend.

Two signals are worth watching. First, royalty revenue trajectory: Arm earns a per-unit fee on every device shipping an Arm-based design, and accelerating AI chip volumes from its broad licensee base would translate directly into royalty upside in coming quarters. Second, capex returns: at 11% of revenue and rising fast, investors will need evidence that the build-out converts into architectural wins or venture-portfolio value — the FY2027 results will be among the earliest tests. Monday's session produced a sharp, unexplained drop. The context surrounding it is a company spending at a pace its recent history has not seen, navigating a market in the process of rewriting the architecture of computation.